Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus

American Journal of Obstetrics and Gynecology

Volumn 180, Issue 4, 1999, Pages 824-836

  Minkoff, Howard L ^a   Eisenberger Matityahu, Debra ^b   Feldman, Joseph ^b   Burk, Robert ^b   Clarke, Lorraine ^b  

^a MAIMONIDES MEDICAL CENTER   (United States)

^b NONE

Author keywords

Gynecologic disorders; Human immunodeficiency virus; Women

Indexed keywords

CD4 ANTIGEN;

ADULT; CHLAMYDIA TRACHOMATIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GYNECOLOGIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; MYCOSIS; OUTCOMES RESEARCH; PAPANICOLAOU TEST; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; TREPONEMA PALLIDUM; VAGINA CANDIDIASIS; VIRUS SHEDDING; WART VIRUS;

EID: 0032902078     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70653-8     Document Type: Conference Paper

References (45)

1. 1. Centers for Disease Control and Prevention. 1997 World AIDS Day. MMWR Morb Mortal Wkly Rep 1997;46:1085.
2. 2. Centers for Disease Control. HIV testing among women aged 18-44 years - United States, 1991 and 1993. MMWR Morb Mortal Wkly Rep 1996;45:733-7.
3. 3. Centers for Disease Control. Update: mortality attributable to HIV infection/AIDS among persons aged 25-44 years - United States, 1990 and 1991. MMWR Morb Mortal Wkly Rep 1993;42:481-6.
4. 4. Rosenberg PS. Scope of the AIDS epidemic in the United States. Science 1995;270:1372.
5. 5. Chirgwin KD, Feldman J, Muneyyirci-Delale O, Landesman S, Minkoff H. Menstrual function in human immunodeficiency virus-infected women without acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1996;12:489-94.
6. 6. Duerr AC, Sierra MF, Feldman J, Landesman S, Clarke LM, Ehrlich I, et al. Immune compromise and prevalence of Candida vulvovaginitis in HIV-infected women. Obstet Gynecol 1997;90(2):252-6.
7. 7. Chirgwin KD, Feldman J, Augenbraun M, Landesman S, Minkoff H. Incidence of venereal warts in human immunodeficiency virus-infected and uninfected women. J Infect Dis 1995;172:235-8.
8. 8. Rhoads SL, Wright C, Redfield RR, Burke DS. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 1987;257:3105-7.
9. 9. Imam N, Carpenter GCJ, Mayer KH, Fisher A, Stein M, Danforth SB. Hierarchical pattern of mucosal candida infections in HIV-seropositive women. Am J Med 1990;89:142-6.
10. 9a. Minkoff H, Feldman J, DeHovitz J, Landesman S, Burk R. A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol 1998;178:982-6.
11. 10. Ho GYF, Burk RD, Fleming I, Klein RS. Risk of genital human papilloma virus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer 1994;56:788-92.
12. 11. Sun XW, Ellerbrock TV, Lungu O, Chiasson MA, Bush TJ, Wright TC. Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol 1995;85:680-6.
13. 12. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343-9.
14. 13. Vernon SD, Reeves WC, Clancy KA, Laga M, St Louis M, Gary HE, et al. A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women. J Infect Dis 1994;169:1108-12.
15. 13a. Minkoff H, Feldman J, DeHovitz J, Landesman S, Burk R. A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol 1998;178:982-6.
16. 14. Frankel RE, Selwyn PA, Mezger J, Andrews S. High prevalence of gynecologic disease among hospitalized women with human immunodeficiency virus infection. Clin Infect Dis 1997;25:706-12.
17. 15. Madge S, Elford J, Lipman MCI, Mintz J, Johnson MA. Screening for sexually transmitted diseases in an HIV testing clinic: uptake and prevalence. Genitourin Med 1996;72:347-51.
18. 16. Tweddel G, Heller P, Cunnane M, Multhaupt H, Roth K. The correlation between HIV seropositivity, cervical dysplasia, and HPV subtypes 6/11, 16/18, 31/33/35. Gynecol Oncol 1994;34:1-4.
19. 17. Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 1994;83:205-11.
20. 18. Shah PN, Smith JR, Wells C, Barton SE, Kitchen VS, Steer PJ. Menstrual symptoms in women infected by the human immunodeficiency virus. Obstet Gynecol 1994;83:397-400.
21. 19. LaGuardia KD, White MH, Saigo PE, Hoda S, McGuinness K, Ledger WJ. Genital ulcer disease in women infected with human immunodeficiency virus. Am J Obstet Gynecol 1995;172:553-62.
22. 20. Rompalo AM, Cannon RO, Quinn TC, Hook EW III. Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection. J Infect Dis 1992;165:1124-6.
23. 21. Cohen CR, Duerr A, Pruithithada N, Rugpao S, Hillier S, Garcia P, et al. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 1995;9:1093-7.
24. 22. Dehovitz JA, Kelly P, Feldman J, Sierra MF, Clarke L, Bromberg J, et al. Sexually transmitted diseases, sexual behavior, and cocaine use in inner-city women. Am J Epidemiol 1994;140:1125-34.
25. 23. Burk RD, Ho GYF, Beardsley L, Lempa M, Peters M, Bierman R. Sexual practices and partner selection are the predominant risk factors for genital HPV infection in young women. J Infect Dis 1996;174:679-89.
26. 24. Tachezy R, Van Ranst MA, Cruz Y, Burk RD. Analysis of short novel human papillomavirus sequences. Bioehem Biophys Res Commun 1994;204:820-7.
27. 25. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
28. 26. Ho GYF, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
29. 27. Jiang G, Qu W, Ruan H, Burk RD. Elimination of false-positive signals in enhanced chemiluminescence detection of amplified HPV DNA from clinical samples. Biotechniques 1995;19:566-8.
30. 28. Qu W, Jiang G, Cruz Y, Chiang CJ, Ho GYF, Klein RS, et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997;35:1304-10.
31. 29. Clarke LM, Daidone BJ, Inghida R, Kirwin M, Sierra MF. Differential recovery of cytomegalovirus from cellular and supernatant components of brochoalveolar lavage specimens. Am J Clin Pathol 1992;97:313-7.
32. 30. Centers for Disease Control and Prevention. Interpretation and use of the Western blot assay for scrodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep 1989;38(S-7):1-7.
33. 31. Ashley RL, Miltoni J, Lee F, Nahmias A, Corey L. Comparison of Western blot and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 1988;26:662-7.
34. 32. Maiman M, Fruchter R, Sedlis A, et al. Prevalence, risk factors and accuracy of cytologic screening for intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol 1998;68:233-9.
35. 33. Minkoff HL, Ebrlich I, Feldman J, Holman S, Fazili S, Augenbraun M. Reproductive health hospitalizations among women with HIV infections Am J Obstet Gynecol 1998;178:166-70.
36. 34. Carpenter CC, Mayer KH, Fisher A, Desai MB, Durand L. Natural history of acquired immunodeficiency syndrome in women in Rhode Island. Am J Med 1989;86(6 Pt 2):771-5.
37. 35. DeFasio K, Beuhler J, Kelly JJ, et al. Provision of gynecologic care at outpatient medical facilities serving HIV-infected persons. Am J Womens Health 1992;1:193-6.
38. 36. Clark RA, Brandon W, Dumestre J, Pindaro C. Clinical manifestations of infection with the human immunodeficiency virus in women in Louisiana. Clin Infect Dis 1993;17:165-72.
39. 37. Clark LM, Duerr A, Feldman J, Sierra MF, Daidone BJ, Landesman SH. Factors associated with cytomegalovirus infection among human immunodeficiency virus type-1 seronegative and seropositive women from an urban minority community. J Infect Dis 1996;173:77-82.
40. 38. Augenbraun M, Minkoff H. Biologic false-positive tests for syphilis in HIV infected women. Clin Infect Dis 1994;19:1040-4.
41. 39. Fruchter RG, Maiman M, Sedlis A, Bartley L, Camilien L, Arrastiaa CD. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol 1996;87:338-44.
42. 40. Wilson T, Minkoff HL, DeHovitz J, Feldman J, Landesman S. The relationship of cocaine use to incident sexually transmitted diseases in human immunodeficiency virus infected and uninfected. Sex Transm Dis 1998;25:70-5.
43. 41. Zenilman J, Erickson B, Fox R, Reichart C, Hook E. Effect of HIV posttest counselling on STD incidence. JAMA 1992;267:843-5.
44. 42. Minkoff H, Remington J, Holman S, Ramirez R, Goodwill S, Landesman S. Vertical transmission of toxoplasma by HIV-infected women. Am J Obstet Gynecol 1997;176:555-9.
45. 43. Korn AP, Abercrombie PD. Gynecology and family planning care for the woman infected with HIV. Obstet Gynecol Clin North Am 1997;24:855-72.